Logo image
Sign in
Barriers to the Access of Bevacizumab in Patients with Solid Tumors and the Potential Impact of Biosimilars: A Physician Survey
Journal article   Peer reviewed

Barriers to the Access of Bevacizumab in Patients with Solid Tumors and the Potential Impact of Biosimilars: A Physician Survey

Bradley J. Monk, P. E. Lammers, T. Cartwright and I. Jacobs
Pharmaceuticals (Basel, Switzerland), Vol.10(1), p.(11 pages)
01/2017
PMID: 28134851

Metrics

3 Record Views

Details